ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,735,455, issued on Sept. 15, was assigned to UNIVERSITAT BASEL (Basel, Switzerland).

"Hemostatic elastin-like polypeptides" was invented by Michael Adam Nash (Basel, Switzerland) and Ivan Urosev (Zurich).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a hemostatic elastin-like polypeptide comprising a glutamine embedded in a Q-block sequence and, optionally, a lysine embedded in a K-block sequence. Under physiological setting, the Q-block sequence and the K-block sequence are recognized by human transglutaminase factor XIIIa and crosslinked with fibrin networks. The present invention also relates to the medical use of the...